vorasidenib

CHEBI:CHEBI_752322

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
vorasidenib
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
route
ORAL
dosage_form
TABLET, FILM COATED
active_ingredient_strength
10 mg/1
pharm_class_moa
Isocitrate Dehydrogenase 2 Inhibitors [MoA]
nui
N0000193614
marketing_start_date
20240807
package_marketing_start_date
20240807
brand_name
VORANIGO
brand_name_base
VORANIGO
product_ndc
72694-879
application_number
NDA218784
labeler_name
Servier Pharmaceuticals LLC
manufacturer_name
Servier Pharmaceuticals LLC
spl_id
e2dc4740-f5b0-41bf-b67b-db3168a1c360
active_ingredient_name
VORASIDENIB
package_ndc
72694-879-10
package_description
1 BOTTLE in 1 CARTON (72694-879-10) / 30 TABLET, FILM COATED in 1 BOTTLE
rxcui
2690663
unii
789Q85GA8P
spl_set_id
31405fee-55b7-4857-987e-2724ee76be84
pharm_class_epc
Isocitrate Dehydrogenase 2 Inhibitor [EPC]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class